AzTrials
AzTrials

Atrial FlutterVERISMARTNCT02490033

The VERISMART Trial

A study testing Ablation Catheter in people with Atrial Flutter, run by The Leeds Teaching Hospitals NHS Trust at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Catheter ablation is now routinely used in the management of heart rhythm disorders. One of the problems with the approach is that it has not been possible to determine whether the ablation catheter is in direct contact with the heart tissue or not. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Atrial Flutter
What is being tested?
Ablation Catheter
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
133 participants
Where
1 siteUnited Kingdom
Study dates
1 Apr 2015to 28 Oct 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥18 years
  • Documented paroxysmal or persistent atrial flutter

Who cannot join

  • Inability or unwillingness to receive oral anticoagulation
  • Previous ablation procedure for AFL
  • Unwillingness or inability to complete the required follow up arrangements
  • Concomitant atrial fibrillation

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Leeds Teaching Hospitals NHS Trust

    Leeds, LS1 3HE,

Other trials in United Kingdom

About this study

Official title: Randomised Trial Comparing Conventional Versus Contact Force and Electrical Coupling Index in Atrial Flutter Ablation

Catheter ablation is now routinely used in the management of heart rhythm disorders. One of the problems with the approach is that it has not been possible to determine whether the ablation catheter is in direct contact with the heart tissue or not. This is important because too much contact has safety implications and too little means that the therapy will be ineffective. Recently two different technologies have been developed to determine contact. Currently it is not know if one is superior to the other, and the objective of this trial is to determine whether there is a difference when treating a rhythm called atrial flutter.

Conditions
Atrial Flutter
Being tested
Ablation Catheter
Medical subject headings
Atrial Flutter

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ablation CatheterDevice

Study groups in NCT02490033
Study groupRoleWhat they receive
Contact force unblindedOtherNot described
Receives: Device: Ablation Catheter
Contact force blindedOtherNot described
Receives: Device: Ablation Catheter
ECI unblindedOtherNot described
Receives: Device: Ablation Catheter
ECI blindedOtherNot described
Receives: Device: Ablation Catheter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to achieve bi-directional block

    Time to achieve bi-directional block (secs) . This is defined as the time from the first lesion to the time that consistent (< one minute) bidirectional block is achieved.

    Total RF energy required for the whole procedure (sec), and total energy required for ablation (power x ablation time in secs).

    Measured: up to 60 Seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jul 2015 (estimated)
  2. Study start1 Apr 2015
  3. Primary completion6 Jan 2017
  4. Study completion28 Oct 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
133 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02490033
Sponsor's protocol ID
CD13/11009
Other IDs
14/YH/0038
Acronym
VERISMART
Status last verified
Aug 2019
First submitted
18 May 2015
Last updated
8 Aug 2019
Results posted
No
Data monitoring committee
No

Publications

  • Begg GA, O'Neill J, Sohaib A, McLean A, Pepper CB, Graham LN, Hogarth AJ, Page SP, Gillott RG, Hill N, Walshaw J, Schilling RJ, Kanagaratnam P, Tayebjee MH. Multicentre randomised trial comparing contact force with electrical coupling index in atrial flutter ablation (VERISMART trial). PLoS One. 2019 Apr 3;14(4):e0212903. doi: 10.1371/journal.pone.0212903. eCollection 2019.

    PubMed 30943196

Questions about this trial

What is this clinical trial studying?

A study testing Ablation Catheter in people with Atrial Flutter, run by The Leeds Teaching Hospitals NHS Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to achieve bi-directional block (time frame: up to 60 Seconds). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02490033, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in